UK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after encouraging topline results from a phase 2 study that started last March. The inhaled ...
The Breath-A-Tech Portable Nebuliser is recommended for delivering asthma and COPD medication where pMDI and spacer cannot be utilised. This compact and lightweight device utilises Active Vibrating ...
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results